BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo.
about
Inhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct versus Indirect MechanismsVaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligandsInhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family proteinsMolecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2Pharmacological manipulation of cell death: clinical applications in sight?Inhibition of regulated cell death by cell-penetrating peptidesRegulated necrotic cell death: the passive aggressive side of Bax and BakExtracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injuryAn anti-apoptotic peptide improves survival in lethal total body irradiation.Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitroGlutamine Reduces the Apoptosis of H9C2 Cells Treated with High-Glucose and Reperfusion through an Oxidation-Related Mechanism.Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications.Cell-permeable intrinsic cellular inhibitors of apoptosis protect and rescue intestinal epithelial cells from radiation-induced cell death.Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo.Dissecting the in vivo leukemogenic potency of BCLxl.Apoptosis and caspases regulate death and inflammation in sepsis.HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice.TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice.Sodium orthovanadate (vanadate), a potent mitigator of radiation-induced damage to the hematopoietic system in miceSildenafil augments early protective transcriptional changes after ischemia in mouse myocardiumTwenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptorTargeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.The Antiapoptosis Effect of Glycyrrhizate on HepG2 Cells Induced by Hydrogen Peroxide.Molecular participants in mitochondrial cell death channel formation during neuronal ischemia.Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xLApoptosis: why and how does it occur in biology?Contributions of Bcl-xL to acute and long term changes in bioenergetics during neuronal plasticity.Mitochondrial channels: ion fluxes and more.Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain.Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domainThe N-terminal helix of Bcl-xL targets mitochondria.Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism.Detrimental effects of antiapoptotic treatments in spinal cord injury.A double point mutation at residues Ile14 and Val15 of Bcl-2 uncovers a role for the BH4 domain in both protein stability and function.Paclitaxel Reduces Axonal Bclw to Initiate IP3R1-Dependent Axon Degeneration.Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation.TAT-BH4 counteracts Abeta toxicity on capillary endothelium.Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells.Alpha 5/6 helix domains together with N-terminus determine the apoptotic potency of the Bcl-2 family proteins.
P2860
Q21296696-4CE1D247-7362-4D87-81AE-2B3FE52835FCQ24321449-0C16822B-BDDE-4539-9C40-2ABB2CEF992BQ24324220-406C4916-C3E2-44BF-8989-E12FA2A46754Q24336091-2A5EB998-65A7-436B-ADC8-98D599A60D9FQ24536101-3809FB89-E092-4C3A-98A3-85D653291C2CQ26751423-C7F4688E-8A0F-4CB3-9FF7-CE35F571B1BAQ27021740-1F96A0E9-E555-41ED-A9BB-ECB2BAE419ECQ27334837-59F19E3D-DFAB-4E1C-9364-6133D0565927Q33789426-A3BED4B1-13D2-4756-98C4-E19B31A9F01DQ34392758-CF5A5046-1D64-4C98-8DD2-A65AD9DEF538Q35683182-A2290435-5A0C-4502-A904-017B354B5D4DQ36050486-C836B1F3-9CC2-4B1A-80BB-9597C2162E7BQ36067026-1489EF01-6025-4BD0-BF4C-5B5395FB4086Q36316659-8C491D07-3450-46B3-A943-BBFAF7B9EF7CQ36337499-507BEB27-C3B4-4D4D-8FDE-F6FB887C1452Q36622618-2E6213B5-56E3-424F-9832-F919B94DE507Q36667270-BC00101B-B925-46AB-862F-42D7BAC845FBQ36868764-29C839CE-00FF-48A0-B0AA-0ADF67BA4543Q37006942-7D1C4274-4892-4385-BC20-BB435ABC038BQ37115656-A3295CE9-CD9F-4593-A595-6CAB1BBE54A6Q37230918-BFC8B825-CA80-434A-A1CD-44D4C4DB7686Q37308429-80A3E81C-50B0-4172-AB5A-5437967F6C29Q37341230-344B23BC-D26B-4019-8B3B-02742AF24206Q37424275-F192CEA1-B96F-4373-9C91-673667A191A5Q37430520-3843A381-AEF5-443B-AE9F-B01A3D4C48F4Q37580188-92616928-649B-41A2-9E5C-56B1204A693AQ37902996-BB84E39D-E548-4DFB-9620-049A872758FAQ38163284-759727ED-EA22-44E3-8739-3C42D5DE13ABQ38201407-3CD42349-8770-4B9E-A7FF-61EC7943CD18Q38756877-873EF3EA-F06A-4E99-9CA8-46BFF69B9783Q38887404-A5D39000-1E6B-46FA-ADDB-980E1035168BQ40591457-4DE6513B-A020-4E3D-815D-B66FFD8F5D45Q41432708-2C204C0C-85DD-4913-AF5D-F577EAB03C7FQ42785284-40DB00EA-4D75-4C4F-A66B-4AA189E57392Q47409394-FD0744F7-7EC6-49E8-B6BF-8788D4340381Q47661789-ABCD2895-2980-475F-80EF-467CE95CF3FAQ47838233-7419AE1D-8A13-4BA3-995B-B2936ABF588EQ48287593-D7E5B9A0-EEFE-4A74-B4E3-D913F7EDBDBEQ48645834-CF60295A-A024-4CA9-A941-36E56DA7114BQ51188185-A937B6A1-523E-413C-AB2D-2406F34B357C
P2860
BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo.
@en
type
label
BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo.
@en
prefLabel
BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo.
@en
P2093
P2860
P356
P1433
P1476
BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo.
@en
P2093
Hiroshi Tamagawa
Rie Sugioka
Shigeomi Shimizu
Toru Kawakami
Toshihiro Funatsu
Yoshihide Tsujimoto
Yoshiki Sawa
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207180
P407
P577
2003-11-01T00:00:00Z
P5875
P6179
1026331936